Skip to main content

ADVERTISEMENT

serous carcinoma

Research in Review
03/21/2017
JCP Editors
Women with stage II-IV low-grade serous carcinoma of the ovary or peritoneum who received hormonal maintenance therapy after primary treatment had longer progression-free survival (PFS) compared with women who...
Women with stage II-IV low-grade serous carcinoma of the ovary or peritoneum who received hormonal maintenance therapy after primary treatment had longer progression-free survival (PFS) compared with women who...
Women...
03/21/2017
Journal of Clinical Pathways